Leukemia, Myeloid, Chronic, BCR-ABL Positive

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00619Imatinib3Completed1
DB04868Nilotinib3Completed1